Trametinib is a selective MEK1 and MEK2 kinase inhibitor used in oncology for the treatment of patients with BRAF-mutated melanoma and various solid tumors. This category includes a comprehensive selection… Read more
![Chemical structure of (2S,3S,4S,5R,6S)-6-(2-Amino-4-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1620017-28-8-2S3S4S5R6S-6-2-Amino-4-3-cyclopropyl-5-2-fluoro-4-iodophenylamino-68-dimethyl-247-trioxo-3467-tetrahydropyrido43-dpyrimidin-12H-ylphenoxy.png&w=3840&q=75)
![Chemical structure of 1-(3-Amino-4-hydroxyphenyl)-3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethylpyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1620017-29-9-1-3-Amino-4-hydroxyphenyl-3-cyclopropyl-5-2-fluoro-4-iodophenylamino-68-dimethylpyrido43-dpyrimidine-2471H3H6H-trione.png&w=3840&q=75)
![Chemical structure of 1-(3-Aminophenyl)-3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethylpyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F871701-87-0-1-3-Aminophenyl-3-cyclopropyl-5-2-fluoro-4-iodophenylamino-68-dimethylpyrido43-dpyrimidine-2471H3H6H-trione.png&w=3840&q=75)


![Chemical structure of 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F871700-24-2-3-Cyclopropyl-1-2-fluoro-4-iodophenyl-5-hydroxy-68-dimethylpyrido23-dpyrimidine-2471H3H8H-trione.png&w=3840&q=75)
![Chemical structure of 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl 4-methylbenzenesulfonate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F871700-32-2-3-Cyclopropyl-1-2-fluoro-4-iodophenyl-68-dimethyl-247-trioxo-123478-hexahydropyrido23-dpyrimidin-5-yl-4-methylbenzenesulfonate.png&w=3840&q=75)

![Chemical structure of 3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-1-(2-methylquinolin-7-yl)pyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-Cyclopropyl-5-2-fluoro-4-iodophenylamino-68-dimethyl-1-2-methylquinolin-7-ylpyrido43-dpyrimidine-2471H3H6H-trione.png&w=3840&q=75)
![Chemical structure of 3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-1-(3-nitrophenyl)pyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1279693-89-8-3-Cyclopropyl-5-2-fluoro-4-iodophenylamino-68-dimethyl-1-3-nitrophenylpyrido43-dpyrimidine-2471H3H6H-trione.png&w=3840&q=75)









![Chemical structure of N-(1-(3-Aminophenyl)-3-cyclopropyl-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,6,7-hexahydropyrido[4,3-d]pyrimidin-5-yl)-N-(2-fluoro-4-iodophenyl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-1-3-Aminophenyl-3-cyclopropyl-68-dimethyl-247-trioxo-123467-hexahydropyrido43-dpyrimidin-5-yl-N-2-fluoro-4-iodophenylnitrous-amide.png&w=3840&q=75)

![Chemical structure of N-(3-((3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl)(nitroso)amino)phenyl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3-3-Cyclopropyl-1-2-fluoro-4-iodophenyl-68-dimethyl-247-trioxo-123478-hexahydropyrido23-dpyrimidin-5-ylnitrosoaminophenylacetamide.png&w=3840&q=75)
![Chemical structure of N-(3-((3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl)amino)phenyl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F871700-25-3-N-3-3-Cyclopropyl-1-2-fluoro-4-iodophenyl-68-dimethyl-247-trioxo-123478-hexahydropyrido23-dpyrimidin-5-ylaminophenylacetamide.png&w=3840&q=75)
![Chemical structure of N-(3-(3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)(nitroso)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3-3-Cyclopropyl-5-2-fluoro-4-iodophenylnitrosoamino-68-dimethyl-247-trioxo-3467-tetrahydropyrido43-dpyrimidin-12H-ylphenylacetamide.png&w=3840&q=75)
![Chemical structure of N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)-2-hydroxyacetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3-3-cyclopropyl-5-2-fluoro-4-iodophenylamino-68-dimethyl-247-trioxo-3467-tetrahydropyrido43-dpyrimidin-12H-ylphenyl-2-hydroxyacetamide.png&w=3840&q=75)
![Chemical structure of N-(3-(3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)imino)-8-hydroperoxy-6,8-dimethyl-2,4,7-trioxo-3,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1383430-04-3-N-3-3-Cyclopropyl-5-2-fluoro-4-iodophenylimino-8-hydroperoxy-68-dimethyl-247-trioxo-345678-hexahydropyrido43-dpyrimidin-12H-ylphenylaceta.png&w=3840&q=75)
![Chemical structure of N-(3-(3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)imino)-8-hydroxy-6,8-dimethyl-2,4,7-trioxo-3,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1383430-03-2-N-3-3-Cyclopropyl-5-2-fluoro-4-iodophenylimino-8-hydroxy-68-dimethyl-247-trioxo-345678-hexahydropyrido43-dpyrimidin-12H-ylphenylacetamide.png&w=3840&q=75)
![Chemical structure of N-(3-(3-Cyclopropyl-5-((2-fluorophenyl)(nitroso)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3-3-Cyclopropyl-5-2-fluorophenylnitrosoamino-68-dimethyl-247-trioxo-3467-tetrahydropyrido43-dpyrimidin-12H-ylphenylacetamide.png&w=3840&q=75)
![Chemical structure of N-(3-(5-((4-Bromo-2-fluorophenyl)amino)-3-cyclopropyl-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F871700-13-9-N-3-5-4-Bromo-2-fluorophenylamino-3-cyclopropyl-68-dimethyl-247-trioxo-3467-tetrahydropyrido43-dpyrimidin-12H-ylphenylacetamide.png&w=3840&q=75)
















Trametinib is a selective MEK1 and MEK2 kinase inhibitor used in oncology for the treatment of patients with BRAF-mutated melanoma and various solid tumors. This category includes a comprehensive selection of Trametinib reference standards, featuring pharmacopeial and non-pharmacopeial impurities, metabolites such as glucuronides, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for rigorous analytical method validation, impurity profiling, and routine quality control to verify the safety and efficacy of the drug substance. By providing structurally characterized analogs, degradation products, and deuterated standards, this collection supports the identification and quantification of impurities that may occur during synthesis or storage. These materials are essential for adhering to international regulatory guidelines throughout the drug development lifecycle, facilitating precise analytical testing and stability monitoring in complex pharmaceutical matrices.